Merck
CN
Search Within

521-78-8

应用筛选条件
关键词:'521-78-8'
显示 1-1 共 1 条结果 关于 "521-78-8" 范围 论文
Daniel P Petrylak et al.
The Lancet. Oncology, 16(4), 417-425 (2015-03-07)
Patients with metastatic castration-resistant prostate cancer have few treatment options. We investigated the safety and efficacy of lenalidomide, an immunomodulatory agent with anti-angiogenic properties, in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer. In this
1/1